Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 572 of 6351
-
Surgery before IVF may boost baby chances for endometriosis patients
Disease control Recruiting nowEndometriosis is a chronic disease affecting approximately 10% of women of reproductive age. It is strongly associated with pelvic pain and infertility. Women with advanced stages of the disease (stage III-IV) have markedly reduced fertility compared with the general population. …
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Virtual reality workouts could rebuild strength in MS patients
Disease control Recruiting nowTITLE: Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM III. INTRODUCTION: Multiple sclerosis (MS) is a chronic neuroimmunological and degenerative disease characterized by demyelination within the central nervous system. Its clinical course involve…
Sponsor: University of Vigo • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New cord blood booster aims to make cancer transplants safer and faster
Disease control Recruiting nowThis clinical study is testing a new way to improve stem cell transplants for adults with high-risk blood cancers, such as leukemia or myelodysplasia, who do not have a suitable donor. The transplant uses stem cells from umbilical cord blood that have been expanded in the lab usi…
Phase 1/2 • Sponsor: Ciusss de L'Est de l'Île de Montréal • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug could keep stents open after stroke, reducing need for rescue therapy
Disease control Recruiting nowCo-STAR is a multicenter, prospective, open-label, Bayesian Optimal Phase 2 (BOP2) trial that aims to assess the safety and efficacy of adjunctive intravenous TBO-309 in Acute Ischaemic Stroke (AIS) patients with tandem occlusion receiving intra-cranial endovascular thrombectomy …
Phase 2 • Sponsor: ThromBio Pty. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy tailors radiation for advanced nasopharyngeal cancer
Disease control OngoingThis study is aimed to evaluate the efficacy and safety of tislelizumab combined with chemotherapy and response-adapted radiotherapy in patients with de novo metastatic nasopharyngeal carcinoma
Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a simple pill keep nasopharyngeal cancer away?
Disease control OngoingThis Phase III multicenter trial investigates treatment intensification for high-risk, stage T1-2N1M0 nasopharyngeal carcinoma. Patients with high-risk features (\>3 metastatic lymph nodes, necrosis, or confluence) receive concurrent chemoradiotherapy. Those with detectable EBV D…
Phase 3 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New shot may slash cholesterol right after a heart attack
Disease control Recruiting nowThe purpose of this trial is to learn about the effects of inclisiran in people with serious heart conditions (acute coronary syndromes), when this treatment is started early after hospital admission. To do this, researchers will test the effects of inclisiran compared to placebo…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New study tests smart insulin pumps and training to restore low blood sugar warning signs
Disease control Recruiting nowThe purpose of the CLEAR study is to determine the effect on counterregulatory responses (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of hypogl…
Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could routine brain scans catch hidden cancer spread?
Diagnosis Recruiting nowA multi-centre, randomised study, to determine the feasibility of recruiting men and women with metastatic HER2 positive breast cancer to a study with a baseline MRI scan followed by randomising to surveillance by two further six-monthly MRI scans versus no further surveillance o…
Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust • Aim: Diagnosis
Last updated Aug 07, 2026 00:00 UTC
-
Squeeze away chemo pain: gloves and boots may stop nerve damage
Symptom relief Recruiting nowChemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induced peripheral neuropathy. The Lilac Glove and Boot devices apply a low pressure…
Sponsor: Luminate Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New drug aimed at taming Crohn's Flare-Ups enters Late-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug aims to fight deadly wasting in pancreatic cancer patients
Symptom relief Recruiting nowStudy to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ductal adenocardinoma.
Phase 2/3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New drug aims to cut heart deaths in rare heart condition
Disease control Recruiting nowThis study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition called transthyretin amyloid cardiomyopathy (ATTR-CM), which affects the heart. Participants will either receive NNC6019-000…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could chemo keep uterine sarcoma at bay? new trial seeks answers
Disease control Recruiting nowTo find out if receiving standard chemotherapy (doxorubicin and trabectedin) can extend the cancer-free survival of patients with Stage 1b/2 uterine leiomyosarcoma who had surgery that fully removed the tumor.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
AI eye test could save your sight: 4,300-Patient trial launches
Diagnosis Recruiting nowDiabetic retinopathy (DR) and age-related macular degeneration (AMD) are leading causes of vision loss, with rising incidence due to aging populations and increasing diabetes prevalence. However, delayed diagnoses are common due to low disease literacy and lack of dedicated scree…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
AI takes on kidney disease: a new model to forecast Who's at risk
Knowledge-focused OngoingChronic kidney disease (CKD) is a common condition that imposes a substantial health burden and contributes significantly to global morbidity and mortality. In the United States, 2024 data indicate that about 14% of adults - more than 31 million people - have CKD, costing hundred…
Sponsor: University Medical Center Ho Chi Minh City (UMC) • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to save kidneys: 3,000-Patient trial launches
Disease control Not yet recruitingChronic kidney disease CKD is estimated to affect nearly over 800 million people globally today (with roughly 125,000 people ending up annually on dialysis in the United States alone. CKD is a contributor to illness and is associated with a diminished quality of life and reduced …
Phase 2/3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Jun 26, 2026 14:50 UTC
-
Poop pills could save lives of blood cancer patients
Disease control By invitation onlyIn Hungary - in comparison to other member states of the European Union - about 75000 new cases of cancer are diagnosed annually, from which approximately 4500-5000 patients suffer from so-called malignant hematological diseases. This disease group includes various leukemias (blo…
Sponsor: Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a Wrist-Worn sensor outsmart atrial fibrillation?
Diagnosis Recruiting nowThis is a prospective study validating a new machine-learning algorithm that detects atrial fibrillation (AF) from photoplethysmography (PPG) signals, developed for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-process…
Sponsor: Seerlinq s. r. o. • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Boosting radiation may help more rectal cancer patients reach remission
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether new adjuvant radiotherapy with gross tumor volume(GTV) escalated to 58.75 Gy can improve complete response (CR) rates compared with GTV dose of 50 Gy in adult patients (18-79 years) with locally advanced rectal adenocarcinoma (T…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC